# OnCo record nct01310803 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct01310803/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct01310803", "NCT01310803" ;
  schema:name "Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder"@en ;
  schema:description "A phase 3 trial of Valrubicin in Non-muscle-invasive bladder cancer, run by Endo USA Inc., a Keenova Therapeutics Company, recorded as terminated on the registry."@en ;
  schema:url <https://onco.cc/trials/nct01310803/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01310803> ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/non-muscle-invasive-bladder-cancer/> ;
  onco:drugs <https://onco.cc/drugs/valrubicin/> ;
  onco:companies <https://onco.cc/companies/endo/> .